• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症的最新进展

Recent advances in Huntington's disease.

作者信息

Gutekunst C A, Norflus F, Hersch S M

机构信息

Department of Neurology, Emory University School of Medicine, Atlanta GA 30322, USA.

出版信息

Curr Opin Neurol. 2000 Aug;13(4):445-50. doi: 10.1097/00019052-200008000-00013.

DOI:10.1097/00019052-200008000-00013
PMID:10970063
Abstract

Huntington's disease is a progressive and fatal neurological disorder caused by the expansion of a CAG trinucleotide repeat in exon 1 of the gene coding for a protein of unknown function that has been named huntingtin. The exact cause of neuronal death in Huntington's disease is unknown; however, the leading hypothesis is that of excitotoxicity and apoptosis induced by a defect in energy metabolism that may be caused by oxidative stress. How mutant huntingtin might cause these processes is unknown. New animal and cell models provide insights into the mechanism of pathogenesis and the search for the development of effective therapies.

摘要

亨廷顿舞蹈症是一种进行性致命性神经疾病,由编码功能未知蛋白质(命名为亨廷顿蛋白)的基因外显子1中CAG三核苷酸重复序列的扩增引起。亨廷顿舞蹈症中神经元死亡的确切原因尚不清楚;然而,主要假说是由能量代谢缺陷诱导的兴奋性毒性和细胞凋亡,这可能是由氧化应激引起的。突变的亨廷顿蛋白如何引发这些过程尚不清楚。新的动物和细胞模型为发病机制以及有效疗法的研发探索提供了见解。

相似文献

1
Recent advances in Huntington's disease.亨廷顿舞蹈症的最新进展
Curr Opin Neurol. 2000 Aug;13(4):445-50. doi: 10.1097/00019052-200008000-00013.
2
Recent advances on the pathogenesis of Huntington's disease.亨廷顿舞蹈症发病机制的最新进展
Exp Neurol. 1999 May;157(1):1-18. doi: 10.1006/exnr.1998.7006.
3
Animal models of Huntington's disease: from basic research on neuronal death to assessment of new therapeutic strategies.亨廷顿舞蹈症的动物模型:从神经元死亡的基础研究到新治疗策略的评估
Funct Neurol. 2000 Oct-Dec;15(4):239-51.
4
Mutant huntingtin can paradoxically protect neurons from death.突变型亨廷顿蛋白反而能保护神经元免于死亡。
Cell Death Differ. 2008 Mar;15(3):435-42. doi: 10.1038/sj.cdd.4402261. Epub 2007 Nov 2.
5
The molecular biology of Huntington's disease.亨廷顿舞蹈症的分子生物学
Psychol Med. 2001 Jan;31(1):3-14. doi: 10.1017/s0033291799002871.
6
Antiglutamate therapies in Huntington's disease.
J Neural Transm Suppl. 1999;55:97-102. doi: 10.1007/978-3-7091-6369-6_9.
7
Weight loss in Huntington disease increases with higher CAG repeat number.亨廷顿舞蹈症患者的体重减轻程度随CAG重复序列数目的增加而加重。
Neurology. 2008 Nov 4;71(19):1506-13. doi: 10.1212/01.wnl.0000334276.09729.0e.
8
Huntington's disease: pathomechanism and therapeutic perspectives.亨廷顿舞蹈症:发病机制与治疗前景
J Neural Transm (Vienna). 2004 Oct;111(10-11):1485-94. doi: 10.1007/s00702-004-0201-4.
9
Murine Models of Huntington's Disease for Evaluating Therapeutics.用于评估治疗方法的亨廷顿舞蹈症小鼠模型
Methods Mol Biol. 2018;1780:179-207. doi: 10.1007/978-1-4939-7825-0_10.
10
Emerging chemotherapeutic strategies for Huntington's disease.亨廷顿舞蹈症的新兴化疗策略。
Expert Opin Emerg Drugs. 2005 May;10(2):345-63. doi: 10.1517/14728214.10.2.345.

引用本文的文献

1
Potential future neuroprotective therapies for neurodegenerative disorders and stroke.神经退行性疾病和中风的潜在未来神经保护疗法。
Clin Geriatr Med. 2010 Feb;26(1):125-47. doi: 10.1016/j.cger.2009.12.003.
2
Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475.在四名亨廷顿舞蹈症患者中进行人原发性胎儿组织单侧移植:英国神经移植研究(NEST-UK)安全报告,国际标准随机对照试验编号36485475
J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):678-85. doi: 10.1136/jnnp.73.6.678.
3
Psychogenomics: opportunities for understanding addiction.
心理基因组学:理解成瘾问题的机遇
J Neurosci. 2001 Nov 1;21(21):8324-7. doi: 10.1523/JNEUROSCI.21-21-08324.2001.